RSS-Feed abonnieren

DOI: 10.1055/s-0045-1811259
Evaluation of the Prognostic Utility of the Postoperative Inflammatory Burden Index in Colorectal Cancer
Funding The author(s) received no financial support for the research.

Abstract
Introduction
This study aimed to evaluate the significance of the postoperative inflammatory burden index (IBI) as a prognostic marker and to investigate the clinical outcomes of patients with stage II and III colorectal cancer who underwent colorectal surgery.
Methods
This retrospective study included 223 patients who underwent colorectal surgery for stage II and III colorectal cancers. The patients were divided into four groups based on postoperative IBI on days 1 and 7 (high or low): Group 1 (low & low, n = 118), Group 2 (high & low, n = 18), Group 3 (low & high, n = 56), and Group 4 (high & high, n = 31). The clinical impact of the postoperative IBI on recurrence-free survival (RFS) and overall survival (OS) was also evaluated.
Results
High postoperative IBI was significantly associated with decreased RFS and OS. The Kaplan-Meier survival curves for RFS and OS in stage II and III colorectal cancer showed a decline in Groups 2, 3, and 4, with a more pronounced decline observed in Group 4 (p = 0.001 and p = 0.007, respectively).
Conclusions
This study suggests that the postoperative IBI may be a prognostic marker for RFS and OS in patients with stage II and III colorectal cancer. When postoperative IBI on days 1 and 7 is high, these findings may indicate a high-risk factor for the recurrence of colorectal cancer. Postoperative IBI is useful in establishing postoperative oncological surveillance and adjuvant chemotherapy strategies.
Availability of Data and Materials
The data generated in the present study may be requested from the corresponding author.
Authors' Contribution
SF: study design, data collection, interpretation of results, manuscript writing, manuscript editing; MH: study design, data collection, data analysis, interpretation of results, manuscript writing, manuscript editing; NK: data collection, manuscript editing; NKo: data collection, manuscript editing; MS: data collection, manuscript editing; AI: data collection, manuscript editing; RS: data collection, manuscript editing, study supervision, final manuscript approval. All authors read and approved the final manuscript.
Ethics Approval and Consent to Participate
The Medical Ethics Committee of the Japanese Red Cross Society Karatsu Red Cross Hospital reviewed and approved the study design (permission number: 23-I-17–01). All the patients and their families were informed of the surgical procedure and provided written informed consent.
Consent for Publication
Informed broad consent for this study was obtained.
Publikationsverlauf
Eingereicht: 09. März 2025
Angenommen: 22. Mai 2025
Artikel online veröffentlicht:
10. September 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Shunsuke Furukawa, Masatsugu Hiraki, Naoya Kimura, Naohiko Kohya, Masashi Sakai, Akashi Ikubo, Ryuichiro Samejima. Evaluation of the Prognostic Utility of the Postoperative Inflammatory Burden Index in Colorectal Cancer. Journal of Coloproctology 2025; 45: s00451811259.
DOI: 10.1055/s-0045-1811259
-
References
- 1 World Health Organization. . International agency for research on cancer. GLOBOCAN 2022 : Estimated cancer incidence, mortality and prevalence worldwide in 2022. Geneva, Switzerland: WHO. Available at: https://gco.iarc.fr/today
- 2 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
- 3 Fang SH, Efron JE, Berho ME, Wexner SD. Dilemma of stage II colon cancer and decision making for adjuvant chemotherapy. J Am Coll Surg 2014; 219 (05) 1056-1069
- 4 Qiu X, Zhang Y, Zhu Y, Yang M, Tao L. Association of the inflammatory burden index with increased mortality among cancer patients: Insights from the NHANES study. Immun Inflamm Dis 2024; 12 (12) e70067
- 5 Xie H, Ruan G, Wei L. et al. Comprehensive comparative analysis of prognostic value of serum systemic inflammation biomarkers for colorectal cancer: Results from a large multicenter collaboration. Front Immunol 2023; 13: 1092498
- 6 Yamashita S, Okugawa Y, Mizuno N. et al. Inflammatory Burden Index as a promising new marker for predicting surgical and oncological outcomes in colorectal cancer. Ann Gastroenterol Surg 2024; 8 (05) 826-835
- 7 Li X, Zhou Z, Zhou C, Xiong M, Xing C, Wu Y. Preoperative albumin to alkaline phosphatase ratio and inflammatory burden index for rectal cancer prognostic nomogram-construction: Based on multiple machine learning. J Inflamm Res 2024; 17: 11161-11174
- 8 Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91 (03) 181-184
- 9 Pelc Z, Sędłak K, Mlak R. et al. Prognostic value of inflammatory burden index in advanced gastric cancer patients undergoing multimodal treatment. Cancers (Basel) 2024; 16 (04) 828
- 10 Zhao Q, Wang L, Yang X, Feng J, Chen Q. Preoperative inflammatory burden index for prognostication in esophageal squamous cell carcinoma undergoing radical resection. Sci Rep 2024; 14 (01) 30811
- 11 Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240 (02) 205-213
- 12 Katayama H, Kurokawa Y, Nakamura K. et al. Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today 2016; 46 (06) 668-685
- 13 Zhang J, Zhang HY, Li J, Shao XY, Zhang CX. The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis. Oncotarget 2017; 8 (40) 68837-68846
- 14 Ramesh SK, Swain SK, Munikrishnan V, Jameel JKA. Can the inflammatory cell ratio NLR and PLR be used as a reliable marker in colon cancer? A prospective study. Euroasian J Hepatogastroenterol 2023; 13 (02) 61-65
- 15 Acikgoz O, Cakan B, Demir T. et al. Platelet to lymphocyte ratio is associated with tumor localization and outcomes in metastatic colorectal cancer. Medicine (Baltimore) 2021; 100 (44) e27712
- 16 Kasahara K, Enomoto M, Udo R. et al. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study. BMC Cancer 2022; 22 (01) 20
- 17 Shimada A, Matsuda T, Sawada R. et al. The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy. Sci Rep 2023; 13 (01) 17111
- 18 Kamada T, Ohdaira H, Aida T. et al. Visceral obesity and a high Glasgow prognostic score are key prognostic factors for metastatic colorectal cancer treated with first-line chemotherapy. J Anus Rectum Colon 2024; 8 (04) 383-392
- 19 Takeda Y, Sugano H, Okamoto A. et al. Prognostic usefulness of the C-reactive protein-albumin-lymphocyte (CALLY) index as a novel biomarker in patients undergoing colorectal cancer surgery. Asian J Surg 2024; 47 (08) 3492-3498
- 20 Yang M, Lin SQ, Liu XY. et al. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study. Front Immunol 2023; 14: 1131496
- 21 Furukawa K, Tsunematsu M, Tanji Y. et al. Impact of C-reactive protein-albumin-lymphocyte (CALLY) index on prognosis after hepatectomy for colorectal liver metastasis. Surg Oncol 2023; 47: 101911
- 22 Murata M. Inflammation and cancer. Environ Health Prev Med 2018; 23 (01) 50
- 23 Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111 (12) 1805-1812
- 24 Dumitru CA, Lang S, Brandau S. Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. Semin Cancer Biol 2013; 23 (03) 141-148
- 25 Heinzel S, Marchingo JM, Horton MB, Hodgkin PD. The regulation of lymphocyte activation and proliferation. Curr Opin Immunol 2018; 51: 32-38
- 26 Huh JW, Lee JH, Kim HR. Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer. Arch Surg 2012; 147 (04) 366-372
- 27 Aoyama T, Maezawa Y, Hashimoto I. et al. Inflammatory burden index is an independent prognostic factor for esophageal cancer patients who receive curative treatment. In Vivo 2024; 38 (06) 2928-2934
- 28 Song R, Ni H, Huang J. et al. Prognostic value of inflammation-immunity-nutrition score and inflammatory burden index for hepatocellular carcinoma patients after hepatectomy. J Inflamm Res 2022; 15: 6463-6479
- 29 Xie H, Ruan G, Wei L. et al. The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer. J Cachexia Sarcopenia Muscle 2023; 14 (02) 869-878
- 30 Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420 (6917) 860-867
- 31 Artinyan A, Orcutt ST, Anaya DA, Richardson P, Chen GJ, Berger DH. Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients. Ann Surg 2015; 261 (03) 497-505